Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Clemens

Showing results (411-420 of 434) with videos related to

Pageof 44
Sort By:
Lancet (London, England)|August 13, 2021
Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trialFirdausi Qadri, Farhana Khanam, Xinxue Liu, et al.
Lancet (London, England)|July 13, 2015
Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trialFirdausi Qadri, Mohammad Ali, Fahima Chowdhury, et al.
BMC Public Health|May 21, 2005
A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in southeast China: a cluster-randomized trialJin Yang, Camilo J Acosta, Guo-ai Si, et al.
BMC Infectious Diseases|January 31, 2025
Evaluation of naturally occurring IgG anti-Vi antibody titers as predictors and correlates of typhoid fever in Dhaka, BangladeshFarhana Khanam, Natasha Y Rickett, Faisal Ahmmed, et al.
Vaccines|December 23, 2022
Measuring the Effectiveness of COVID-19 Vaccines Used during a Surge of the Delta Variant of SARS-CoV-2 in Bangladesh: A Test-Negative Design EvaluationFarhana Khanam, Md Taufiqul Islam, Faisal Ahmmed, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2026
Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, BangladeshFarhana Khanam, Joo-Young Esther Lee, Faisal Ahmmed, et al.
Tropical Medicine & International Health : TM & IH|December 20, 2005
A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and designCamilo J Acosta, Claudia M Galindo, Mohammad Ali, et al.
Plos One|April 10, 2026
Risk factors for spontaneous abortion following hepatitis E vaccination during and shortly before pregnancy: Further analysis from a cluster-randomized trialAsma Binte Aziz, Faisal Ahmmed, Kassa Haile, et al.
Vaccine|December 5, 2006
Implementation of good clinical practice guidelines in vaccine trials in developing countriesCamilo J Acosta, Claudia M Galindo, R Leon Ochiai, et al.
Microbiome|July 22, 2025
Interplay between the gut microbiome and typhoid fever: insights from endemic countries and a controlled human infection modelPhilip M Ashton, Leonardos Mageiros, James E Meiring, et al.
Pageof 44

Showing results (411-420 of 434) with videos related to

Sort By:
Pageof 44
Lancet (London, England)|August 13, 2021
Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trialFirdausi Qadri, Farhana Khanam, Xinxue Liu, et al.
Lancet (London, England)|July 13, 2015
Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trialFirdausi Qadri, Mohammad Ali, Fahima Chowdhury, et al.
BMC Public Health|May 21, 2005
A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in southeast China: a cluster-randomized trialJin Yang, Camilo J Acosta, Guo-ai Si, et al.
BMC Infectious Diseases|January 31, 2025
Evaluation of naturally occurring IgG anti-Vi antibody titers as predictors and correlates of typhoid fever in Dhaka, BangladeshFarhana Khanam, Natasha Y Rickett, Faisal Ahmmed, et al.
Vaccines|December 23, 2022
Measuring the Effectiveness of COVID-19 Vaccines Used during a Surge of the Delta Variant of SARS-CoV-2 in Bangladesh: A Test-Negative Design EvaluationFarhana Khanam, Md Taufiqul Islam, Faisal Ahmmed, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2026
Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, BangladeshFarhana Khanam, Joo-Young Esther Lee, Faisal Ahmmed, et al.
Tropical Medicine & International Health : TM & IH|December 20, 2005
A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and designCamilo J Acosta, Claudia M Galindo, Mohammad Ali, et al.
Plos One|April 10, 2026
Risk factors for spontaneous abortion following hepatitis E vaccination during and shortly before pregnancy: Further analysis from a cluster-randomized trialAsma Binte Aziz, Faisal Ahmmed, Kassa Haile, et al.
Vaccine|December 5, 2006
Implementation of good clinical practice guidelines in vaccine trials in developing countriesCamilo J Acosta, Claudia M Galindo, R Leon Ochiai, et al.
Microbiome|July 22, 2025
Interplay between the gut microbiome and typhoid fever: insights from endemic countries and a controlled human infection modelPhilip M Ashton, Leonardos Mageiros, James E Meiring, et al.
Pageof 44